Check-Cap Ltd
Business
Check-Cap Ltd is a clinical-stage medical diagnostics company that develops and validated the C-Scan capsule-based colorectal cancer (CRC) screening system but has discontinued active development and is currently evaluating strategic options while maintaining manufactured inventory. The company’s principal product is the C-Scan system comprising an ingestible X‑ray scanning capsule (C-Scan Cap), an external data recorder and positioning patches (C-Scan Track), and analysis software (C-Scan View) for 2D/3D colon imaging. Its operations include clinical development, regulatory engagement and R&D, and it maintains subsidiaries in the U.S. and Canada. C-Scan has been tested and pursued regulatory pathways in the United States, Europe and Israel and is intended to be prescribed by physicians and distributed through clinical and hospital channels and potential commercial partners.
Summary from filing dated 2025-08-27
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $4.14M |
| Total assets | $7.49M |
| Total liabilities | — |
| Stockholders' equity | $3.44M |
| Operating cash flow | $-46.0K |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Check-Cap Ltd's CIK number?
Check-Cap Ltd's SEC CIK number is 0001610590 (1610590). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Check-Cap Ltd's SEC filings?
All of Check-Cap Ltd's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.